1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global DNA Repair Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 PARP Inhibitors 1.2.3 Other 1.3 Market Segment by Application 1.3.1 Global DNA Repair Drugs Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Oncological 1.3.3 Stroke 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global DNA Repair Drugs Market Size (2017-2028) 2.1.1 Global DNA Repair Drugs Revenue (2017-2028) 2.1.2 Global DNA Repair Drugs Sales (2017-2028) 2.2 Global DNA Repair Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global DNA Repair Drugs Sales by Regions (2017-2022) 2.2.2 Global DNA Repair Drugs Revenue by Regions (2017-2022) 2.3 Global DNA Repair Drugs Market Size Forecast by Region 2.3.1 Global DNA Repair Drugs Sales Forecast by Region (2023-2028) 2.3.2 Global DNA Repair Drugs Revenue Forecast by Region (2023-2028) 2.4 Global Top DNA Repair Drugs Regions (Countries) Ranking by Market Size 2.5 DNA Repair Drugs Market Dynamics 2.5.1 DNA Repair Drugs Market Trends 2.5.2 DNA Repair Drugs Market Drivers 2.5.3 DNA Repair Drugs Market Challenges 2.5.4 DNA Repair Drugs Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top DNA Repair Drugs Manufacturers by Sales (2017-2022) 3.1.1 Global DNA Repair Drugs Sales by Manufacturers (2017-2022) 3.1.2 Global DNA Repair Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by DNA Repair Drugs Sales in 2021 3.2 Global Top Manufacturers DNA Repair Drugs by Revenue 3.2.1 Global DNA Repair Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Top DNA Repair Drugs Manufacturers Covered: Ranking by Revenue 3.2.3 Global DNA Repair Drugs Revenue Share by Manufacturers (2017-2022) 3.2.4 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2021) 3.4 Global DNA Repair Drugs Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers DNA Repair Drugs Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into DNA Repair Drugs Market 3.7 Key Manufacturers DNA Repair Drugs Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global DNA Repair Drugs Market Size by Type 4.1 Global DNA Repair Drugs Historic Market Review by Type (2017-2022) 4.1.1 Global DNA Repair Drugs Sales Market Share by Type (2017-2022) 4.1.2 Global DNA Repair Drugs Revenue Market Share by Type (2017-2022) 4.1.3 DNA Repair Drugs Price by Type (2017-2022) 4.2 Global DNA Repair Drugs Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global DNA Repair Drugs Sales Forecast by Type (2023-2028) 4.2.2 Global DNA Repair Drugs Revenue Forecast by Type (2023-2028) 4.2.3 DNA Repair Drugs Price Forecast by Type (2023-2028) 5 Global DNA Repair Drugs Market Size by Application 5.1 Global DNA Repair Drugs Historic Market Review by Application (2017-2022) 5.1.1 Global DNA Repair Drugs Sales Market Share by Application (2017-2022) 5.1.2 Global DNA Repair Drugs Revenue Market Share by Application (2017-2022) 5.1.3 DNA Repair Drugs Price by Application (2017-2022) 5.2 Global DNA Repair Drugs Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global DNA Repair Drugs Sales Forecast by Application (2023-2028) 5.2.2 Global DNA Repair Drugs Revenue Forecast by Application (2023-2028) 5.2.3 DNA Repair Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America DNA Repair Drugs Sales Breakdown by Company 6.1.1 North America DNA Repair Drugs Sales by Company (2017-2022) 6.1.2 North America DNA Repair Drugs Revenue by Company (2017-2022) 6.2 North America DNA Repair Drugs Market Size by Type 6.2.1 North America DNA Repair Drugs Sales by Type (2017-2028) 6.2.2 North America DNA Repair Drugs Revenue by Type (2017-2028) 6.3 North America DNA Repair Drugs Market Size by Application 6.3.1 North America DNA Repair Drugs Sales by Application (2017-2028) 6.3.2 North America DNA Repair Drugs Revenue by Application (2017-2028) 6.4 North America DNA Repair Drugs Market Size by Country 6.4.1 North America DNA Repair Drugs Sales by Country (2017-2028) 6.4.2 North America DNA Repair Drugs Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe DNA Repair Drugs Sales Breakdown by Company 7.1.1 Europe DNA Repair Drugs Sales by Company (2017-2022) 7.1.2 Europe DNA Repair Drugs Revenue by Company (2017-2022) 7.2 Europe DNA Repair Drugs Market Size by Type 7.2.1 Europe DNA Repair Drugs Sales by Type (2017-2028) 7.2.2 Europe DNA Repair Drugs Revenue by Type (2017-2028) 7.3 Europe DNA Repair Drugs Market Size by Application 7.3.1 Europe DNA Repair Drugs Sales by Application (2017-2028) 7.3.2 Europe DNA Repair Drugs Revenue by Application (2017-2028) 7.4 Europe DNA Repair Drugs Market Size by Country 7.4.1 Europe DNA Repair Drugs Sales by Country (2017-2028) 7.4.2 Europe DNA Repair Drugs Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific DNA Repair Drugs Sales Breakdown by Company 8.1.1 Asia Pacific DNA Repair Drugs Sales by Company (2017-2022) 8.1.2 Asia Pacific DNA Repair Drugs Revenue by Company (2017-2022) 8.2 Asia Pacific DNA Repair Drugs Market Size by Type 8.2.1 Asia Pacific DNA Repair Drugs Sales by Type (2017-2028) 8.2.2 Asia Pacific DNA Repair Drugs Revenue by Type (2017-2028) 8.3 Asia Pacific DNA Repair Drugs Market Size by Application 8.3.1 Asia Pacific DNA Repair Drugs Sales by Application (2017-2028) 8.3.2 Asia Pacific DNA Repair Drugs Revenue by Application (2017-2028) 8.4 Asia Pacific DNA Repair Drugs Market Size by Region 8.4.1 Asia Pacific DNA Repair Drugs Sales by Region 8.4.2 Asia Pacific DNA Repair Drugs Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America DNA Repair Drugs Sales Breakdown by Company 9.1.1 Latin America DNA Repair Drugs Sales by Company (2017-2022) 9.1.2 Latin America DNA Repair Drugs Revenue by Company (2017-2022) 9.2 Latin America DNA Repair Drugs Market Size by Type 9.2.1 Latin America DNA Repair Drugs Sales by Type (2017-2028) 9.2.2 Latin America DNA Repair Drugs Revenue by Type (2017-2028) 9.3 Latin America DNA Repair Drugs Market Size by Application 9.3.1 Latin America DNA Repair Drugs Sales by Application (2017-2028) 9.3.2 Latin America DNA Repair Drugs Revenue by Application (2017-2028) 9.4 Latin America DNA Repair Drugs Market Size by Country 9.4.1 Latin America DNA Repair Drugs Sales by Country (2017-2028) 9.4.2 Latin America DNA Repair Drugs Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa DNA Repair Drugs Sales Breakdown by Company 10.1.1 Middle East and Africa DNA Repair Drugs Sales by Company (2017-2022) 10.1.2 Middle East and Africa DNA Repair Drugs Revenue by Company (2017-2022) 10.2 Middle East and Africa DNA Repair Drugs Market Size by Type 10.2.1 Middle East and Africa DNA Repair Drugs Sales by Type (2017-2028) 10.2.2 Middle East and Africa DNA Repair Drugs Revenue by Type (2017-2028) 10.3 Middle East and Africa DNA Repair Drugs Market Size by Application 10.3.1 Middle East and Africa DNA Repair Drugs Sales by Application (2017-2028) 10.3.2 Middle East and Africa DNA Repair Drugs Revenue by Application (2017-2028) 10.4 Middle East and Africa DNA Repair Drugs Market Size by Country 10.4.1 Middle East and Africa DNA Repair Drugs Sales by Country (2017-2028) 10.4.2 Middle East and Africa DNA Repair Drugs Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 U.A.E 11 Company Profiles 11.1 4SC AG 11.1.1 4SC AG Corporation Information 11.1.2 4SC AG Overview 11.1.3 4SC AG DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 4SC AG DNA Repair Drugs Products and Services 11.1.5 4SC AG DNA Repair Drugs SWOT Analysis 11.1.6 4SC AG Recent Developments 11.2 ARCAGY/ GINECO GROUP 11.2.1 ARCAGY/ GINECO GROUP Corporation Information 11.2.2 ARCAGY/ GINECO GROUP Overview 11.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products and Services 11.2.5 ARCAGY/ GINECO GROUP DNA Repair Drugs SWOT Analysis 11.2.6 ARCAGY/ GINECO GROUP Recent Developments 11.3 Bristol Myers Squibb 11.3.1 Bristol Myers Squibb Corporation Information 11.3.2 Bristol Myers Squibb Overview 11.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Bristol Myers Squibb DNA Repair Drugs Products and Services 11.3.5 Bristol Myers Squibb DNA Repair Drugs SWOT Analysis 11.3.6 Bristol Myers Squibb Recent Developments 11.4 British Columbia Cancer Agency 11.4.1 British Columbia Cancer Agency Corporation Information 11.4.2 British Columbia Cancer Agency Overview 11.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 British Columbia Cancer Agency DNA Repair Drugs Products and Services 11.4.5 British Columbia Cancer Agency DNA Repair Drugs SWOT Analysis 11.4.6 British Columbia Cancer Agency Recent Developments 11.5 Cambridge University Hospitals NHS Foundation Trust 11.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information 11.5.2 Cambridge University Hospitals NHS Foundation Trust Overview 11.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products and Services 11.5.5 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs SWOT Analysis 11.5.6 Cambridge University Hospitals NHS Foundation Trust Recent Developments 11.6 Genentech 11.6.1 Genentech Corporation Information 11.6.2 Genentech Overview 11.6.3 Genentech DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Genentech DNA Repair Drugs Products and Services 11.6.5 Genentech DNA Repair Drugs SWOT Analysis 11.6.6 Genentech Recent Developments 11.7 Georgetown University 11.7.1 Georgetown University Corporation Information 11.7.2 Georgetown University Overview 11.7.3 Georgetown University DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Georgetown University DNA Repair Drugs Products and Services 11.7.5 Georgetown University DNA Repair Drugs SWOT Analysis 11.7.6 Georgetown University Recent Developments 11.8 German Breast Group 11.8.1 German Breast Group Corporation Information 11.8.2 German Breast Group Overview 11.8.3 German Breast Group DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 German Breast Group DNA Repair Drugs Products and Services 11.8.5 German Breast Group DNA Repair Drugs SWOT Analysis 11.8.6 German Breast Group Recent Developments 11.9 GlaxoSmithKline 11.9.1 GlaxoSmithKline Corporation Information 11.9.2 GlaxoSmithKline Overview 11.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 GlaxoSmithKline DNA Repair Drugs Products and Services 11.9.5 GlaxoSmithKline DNA Repair Drugs SWOT Analysis 11.9.6 GlaxoSmithKline Recent Developments 11.10 Jiangsu Hengrui Medicine 11.10.1 Jiangsu Hengrui Medicine Corporation Information 11.10.2 Jiangsu Hengrui Medicine Overview 11.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products and Services 11.10.5 Jiangsu Hengrui Medicine DNA Repair Drugs SWOT Analysis 11.10.6 Jiangsu Hengrui Medicine Recent Developments 11.11 Johnson & Johnson 11.11.1 Johnson & Johnson Corporation Information 11.11.2 Johnson & Johnson Overview 11.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Johnson & Johnson DNA Repair Drugs Products and Services 11.11.5 Johnson & Johnson Recent Developments 11.12 Jonsson Comprehensive Cancer Center 11.12.1 Jonsson Comprehensive Cancer Center Corporation Information 11.12.2 Jonsson Comprehensive Cancer Center Overview 11.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Products and Services 11.12.5 Jonsson Comprehensive Cancer Center Recent Developments 11.13 Karyopharm Therapeutics 11.13.1 Karyopharm Therapeutics Corporation Information 11.13.2 Karyopharm Therapeutics Overview 11.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Karyopharm Therapeutics DNA Repair Drugs Products and Services 11.13.5 Karyopharm Therapeutics Recent Developments 11.14 KuDOS Pharmaceuticals 11.14.1 KuDOS Pharmaceuticals Corporation Information 11.14.2 KuDOS Pharmaceuticals Overview 11.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Products and Services 11.14.5 KuDOS Pharmaceuticals Recent Developments 11.15 National Health Service 11.15.1 National Health Service Corporation Information 11.15.2 National Health Service Overview 11.15.3 National Health Service DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.15.4 National Health Service DNA Repair Drugs Products and Services 11.15.5 National Health Service Recent Developments 11.16 National Institutes of Health 11.16.1 National Institutes of Health Corporation Information 11.16.2 National Institutes of Health Overview 11.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.16.4 National Institutes of Health DNA Repair Drugs Products and Services 11.16.5 National Institutes of Health Recent Developments 11.17 Tesaro 11.17.1 Tesaro Corporation Information 11.17.2 Tesaro Overview 11.17.3 Tesaro DNA Repair Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.17.4 Tesaro DNA Repair Drugs Products and Services 11.17.5 Tesaro Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 DNA Repair Drugs Value Chain Analysis 12.2 DNA Repair Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 DNA Repair Drugs Production Mode & Process 12.4 DNA Repair Drugs Sales and Marketing 12.4.1 DNA Repair Drugs Sales Channels 12.4.2 DNA Repair Drugs Distributors 12.5 DNA Repair Drugs Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global DNA Repair Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of PARP Inhibitors Table 3. Major Manufacturers of Other Table 4. Global DNA Repair Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global DNA Repair Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global DNA Repair Drugs Sales by Region (2017-2022) & (K Units) Table 7. Global DNA Repair Drugs Sales Market Share by Region (2017-2022) Table 8. Global DNA Repair Drugs Revenue by Region (2017-2022) & (US$ Million) Table 9. Global DNA Repair Drugs Revenue Market Share by Region (2017-2022) Table 10. Global DNA Repair Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 11. Global DNA Repair Drugs Sales Market Share Forecast by Region (2023-2028) Table 12. Global DNA Repair Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 13. Global DNA Repair Drugs Revenue Market Share Forecast by Region (2023-2028) Table 14. Top DNA Repair Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 15. DNA Repair Drugs Market Trends Table 16. DNA Repair Drugs Market Drivers Table 17. DNA Repair Drugs Market Challenges Table 18. DNA Repair Drugs Market Restraints Table 19. Global DNA Repair Drugs Sales by Manufacturers (2017-2022) & (K Units) Table 20. Global DNA Repair Drugs Sales Share by Manufacturers (2017-2022) Table 21. Global DNA Repair Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 22. Ranking of Global Top DNA Repair Drugs Manufacturers by Revenue (US$ Million) in 2021 Table 23. DNA Repair Drugs Revenue Share by Manufacturers (2017-2022) Table 24. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2021) Table 26. Key Manufacturers DNA Repair Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 27. Key Manufacturers DNA Repair Drugs Plants/Factories Distribution Table 28. Key Manufacturers DNA Repair Drugs Area Served Table 29. Date of Key Manufacturers Enter into DNA Repair Drugs Market Table 30. Key Manufacturers DNA Repair Drugs Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global DNA Repair Drugs Sales (K Units) by Type (2017-2022) Table 33. Global DNA Repair Drugs Sales Share by Type (2017-2022) Table 34. Global DNA Repair Drugs Revenue (US$ Million) Market Share by Type (2017-2022) Table 35. Global DNA Repair Drugs Price (K Units) by Type (2017-2022) Table 36. Global DNA Repair Drugs Sales (K Units) by Type (2023-2028) Table 37. Global DNA Repair Drugs Sales Share by Type (2023-2028) Table 38. Global DNA Repair Drugs Revenue (US$ Million) Market Share by Type (2023-2028) Table 39. Global DNA Repair Drugs Revenue Share by Type (2023-2028) Table 40. Global DNA Repair Drugs Price (K Units) by Type (2023-2028) Table 41. Global DNA Repair Drugs Sales (K Units) by Application (2017-2022) Table 42. Global DNA Repair Drugs Sales Share by Application (2017-2022) Table 43. Global DNA Repair Drugs Revenue (US$ Million) Market Share by Application (2017-2022) Table 44. Global DNA Repair Drugs Price (K Units) by Application (2017-2022) Table 45. Global DNA Repair Drugs Sales (K Units) by Application (2023-2028) Table 46. Global DNA Repair Drugs Sales Share by Application (2023-2028) Table 47. Global DNA Repair Drugs Revenue (US$ Million) Market Share by Application (2023-2028) Table 48. Global DNA Repair Drugs Revenue Share by Application (2023-2028) Table 49. Global DNA Repair Drugs Price (K Units) by Application (2023-2028) Table 50. North America DNA Repair Drugs Sales by Company (2017-2022) & (K Units) Table 51. North America DNA Repair Drugs Sales Market Share by Company (2017-2022) Table 52. North America DNA Repair Drugs Revenue by Company (2017-2022) & (US$ Million) Table 53. North America DNA Repair Drugs Revenue Market Share by Company (2017-2022) Table 54. North America DNA Repair Drugs Sales by Type (2017-2022) & (K Units) Table 55. North America DNA Repair Drugs Sales by Type (2023-2028) & (K Units) Table 56. North America DNA Repair Drugs Revenue by Type (2017-2022) & (US$ Million) Table 57. North America DNA Repair Drugs Revenue by Type (2023-2028) & (US$ Million) Table 58. North America DNA Repair Drugs Sales by Application (2017-2022) & (K Units) Table 59. North America DNA Repair Drugs Sales by Application (2023-2028) & (K Units) Table 60. North America DNA Repair Drugs Revenue by Application (2017-2022) & (US$ Million) Table 61. North America DNA Repair Drugs Revenue by Application (2023-2028) & (US$ Million) Table 62. North America DNA Repair Drugs Sales by Country (2017-2022) & (K Units) Table 63. North America DNA Repair Drugs Sales by Country (2023-2028) & (K Units) Table 64. North America DNA Repair Drugs Revenue by Country (2017-2022) & (US$ Million) Table 65. North America DNA Repair Drugs Revenue by Country (2023-2028) & (US$ Million) Table 66. Europe DNA Repair Drugs Sales by Company (2017-2022) & (K Units) Table 67. Europe DNA Repair Drugs Sales Market Share by Company (2017-2022) Table 68. Europe DNA Repair Drugs Revenue by Company (2017-2022) & (US$ Million) Table 69. Europe DNA Repair Drugs Revenue Market Share by Company (2017-2022) Table 70. Europe DNA Repair Drugs Sales by Type (2017-2022) & (K Units) Table 71. Europe DNA Repair Drugs Sales by Type (2023-2028) & (K Units) Table 72. Europe DNA Repair Drugs Revenue by Type (2017-2022) & (US$ Million) Table 73. Europe DNA Repair Drugs Revenue by Type (2023-2028) & (US$ Million) Table 74. Europe DNA Repair Drugs Sales by Application (2017-2022) & (K Units) Table 75. Europe DNA Repair Drugs Sales by Application (2023-2028) & (K Units) Table 76. Europe DNA Repair Drugs Revenue by Application (2017-2022) & (US$ Million) Table 77. Europe DNA Repair Drugs Revenue by Application (2023-2028) & (US$ Million) Table 78. Europe DNA Repair Drugs Sales by Country (2017-2022) & (K Units) Table 79. Europe DNA Repair Drugs Sales by Country (2023-2028) & (K Units) Table 80. Europe DNA Repair Drugs Revenue by Country (2017-2022) & (US$ Million) Table 81. Europe DNA Repair Drugs Revenue by Country (2023-2028) & (US$ Million) Table 82. Asia Pacific DNA Repair Drugs Sales by Company (2017-2022) & (K Units) Table 83. Asia Pacific DNA Repair Drugs Sales Market Share by Company (2017-2022) Table 84. Asia Pacific DNA Repair Drugs Revenue by Company (2017-2022) & (US$ Million) Table 85. Asia Pacific DNA Repair Drugs Revenue Market Share by Company (2017-2022) Table 86. Asia Pacific DNA Repair Drugs Sales by Type (2017-2022) & (K Units) Table 87. Asia Pacific DNA Repair Drugs Sales by Type (2023-2028) & (K Units) Table 88. Asia Pacific DNA Repair Drugs Revenue by Type (2017-2022) & (US$ Million) Table 89. Asia Pacific DNA Repair Drugs Revenue by Type (2023-2028) & (US$ Million) Table 90. Asia Pacific DNA Repair Drugs Sales by Application (2017-2022) & (K Units) Table 91. Asia Pacific DNA Repair Drugs Sales by Application (2023-2028) & (K Units) Table 92. Asia Pacific DNA Repair Drugs Revenue by Application (2017-2022) & (US$ Million) Table 93. Asia Pacific DNA Repair Drugs Revenue by Application (2023-2028) & (US$ Million) Table 94. Asia Pacific DNA Repair Drugs Sales by Region (2017-2022) & (K Units) Table 95. Asia Pacific DNA Repair Drugs Sales by Region (2023-2028) & (K Units) Table 96. Asia Pacific DNA Repair Drugs Revenue by Region (2017-2022) & (US$ Million) Table 97. Asia Pacific DNA Repair Drugs Revenue by Region (2023-2028) & (US$ Million) Table 98. Latin America DNA Repair Drugs Sales by Company (2017-2022) & (K Units) Table 99. Latin America DNA Repair Drugs Sales Market Share by Company (2017-2022) Table 100. Latin America DNA Repair Drugs Revenue by Company (2017-2022) & (US$ Million) Table 101. Latin America DNA Repair Drugs Revenue Market Share by Company (2017-2022) Table 102. Latin America DNA Repair Drugs Sales by Type (2017-2022) & (K Units) Table 103. Latin America DNA Repair Drugs Sales by Type (2023-2028) & (K Units) Table 104. Latin America DNA Repair Drugs Revenue by Type (2017-2022) & (US$ Million) Table 105. Latin America DNA Repair Drugs Revenue by Type (2023-2028) & (US$ Million) Table 106. Latin America DNA Repair Drugs Sales by Application (2017-2022) & (K Units) Table 107. Latin America DNA Repair Drugs Sales by Application (2023-2028) & (K Units) Table 108. Latin America DNA Repair Drugs Revenue by Application (2017-2022) & (US$ Million) Table 109. Latin America DNA Repair Drugs Revenue by Application (2023-2028) & (US$ Million) Table 110. Latin America DNA Repair Drugs Sales by Country (2017-2022) & (K Units) Table 111. Latin America DNA Repair Drugs Sales by Country (2023-2028) & (K Units) Table 112. Latin America DNA Repair Drugs Revenue by Country (2017-2022) & (US$ Million) Table 113. Latin America DNA Repair Drugs Revenue by Country (2023-2028) & (US$ Million) Table 114. Middle East and Africa DNA Repair Drugs Sales by Company (2017-2022) & (K Units) Table 115. Middle East and Africa DNA Repair Drugs Sales Market Share by Company (2017-2022) Table 116. Middle East and Africa DNA Repair Drugs Revenue by Company (2017-2022) & (US$ Million) Table 117. Middle East and Africa DNA Repair Drugs Revenue Market Share by Company (2017-2022) Table 118. Middle East and Africa DNA Repair Drugs Sales by Type (2017-2022) & (K Units) Table 119. Middle East and Africa DNA Repair Drugs Sales by Type (2023-2028) & (K Units) Table 120. Middle East and Africa DNA Repair Drugs Revenue by Type (2017-2022) & (US$ Million) Table 121. Middle East and Africa DNA Repair Drugs Revenue by Type (2023-2028) & (US$ Million) Table 122. Middle East and Africa DNA Repair Drugs Sales by Application (2017-2022) & (K Units) Table 123. Middle East and Africa DNA Repair Drugs Sales by Application (2023-2028) & (K Units) Table 124. Middle East and Africa DNA Repair Drugs Revenue by Application (2017-2022) & (US$ Million) Table 125. Middle East and Africa DNA Repair Drugs Revenue by Application (2023-2028) & (US$ Million) Table 126. Middle East and Africa DNA Repair Drugs Sales by Country (2017-2022) & (K Units) Table 127. Middle East and Africa DNA Repair Drugs Sales by Country (2023-2028) & (K Units) Table 128. Middle East and Africa DNA Repair Drugs Revenue by Country (2017-2022) & (US$ Million) Table 129. Middle East and Africa DNA Repair Drugs Revenue by Country (2023-2028) & (US$ Million) Table 130. 4SC AG Corporation Information Table 131. 4SC AG Description and Overview Table 132. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 133. 4SC AG DNA Repair Drugs Product and Services Table 134. 4SC AG DNA Repair Drugs SWOT Analysis Table 135. 4SC AG Recent Developments Table 136. ARCAGY/ GINECO GROUP Corporation Information Table 137. ARCAGY/ GINECO GROUP Description and Overview Table 138. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 139. ARCAGY/ GINECO GROUP DNA Repair Drugs Product and Services Table 140. ARCAGY/ GINECO GROUP DNA Repair Drugs SWOT Analysis Table 141. ARCAGY/ GINECO GROUP Recent Developments Table 142. Bristol Myers Squibb Corporation Information Table 143. Bristol Myers Squibb Description and Overview Table 144. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 145. Bristol Myers Squibb DNA Repair Drugs Product and Services Table 146. Bristol Myers Squibb DNA Repair Drugs SWOT Analysis Table 147. Bristol Myers Squibb Recent Developments Table 148. British Columbia Cancer Agency Corporation Information Table 149. British Columbia Cancer Agency Description and Overview Table 150. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 151. British Columbia Cancer Agency DNA Repair Drugs Product and Services Table 152. British Columbia Cancer Agency DNA Repair Drugs SWOT Analysis Table 153. British Columbia Cancer Agency Recent Developments Table 154. Cambridge University Hospitals NHS Foundation Trust Corporation Information Table 155. Cambridge University Hospitals NHS Foundation Trust Description and Overview Table 156. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 157. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product and Services Table 158. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs SWOT Analysis Table 159. Cambridge University Hospitals NHS Foundation Trust Recent Developments Table 160. Genentech Corporation Information Table 161. Genentech Description and Overview Table 162. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 163. Genentech DNA Repair Drugs Product and Services Table 164. Genentech DNA Repair Drugs SWOT Analysis Table 165. Genentech Recent Developments Table 166. Georgetown University Corporation Information Table 167. Georgetown University Description and Overview Table 168. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 169. Georgetown University DNA Repair Drugs Product and Services Table 170. Georgetown University DNA Repair Drugs SWOT Analysis Table 171. Georgetown University Recent Developments Table 172. German Breast Group Corporation Information Table 173. German Breast Group Description and Overview Table 174. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 175. German Breast Group DNA Repair Drugs Product and Services Table 176. German Breast Group DNA Repair Drugs SWOT Analysis Table 177. German Breast Group Recent Developments Table 178. GlaxoSmithKline Corporation Information Table 179. GlaxoSmithKline Description and Overview Table 180. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 181. GlaxoSmithKline DNA Repair Drugs Product and Services Table 182. GlaxoSmithKline DNA Repair Drugs SWOT Analysis Table 183. GlaxoSmithKline Recent Developments Table 184. Jiangsu Hengrui Medicine Corporation Information Table 185. Jiangsu Hengrui Medicine Description and Overview Table 186. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 187. Jiangsu Hengrui Medicine DNA Repair Drugs Product and Services Table 188. Jiangsu Hengrui Medicine DNA Repair Drugs SWOT Analysis Table 189. Jiangsu Hengrui Medicine Recent Developments Table 190. Johnson & Johnson Corporation Information Table 191. Johnson & Johnson Description and Overview Table 192. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 193. Johnson & Johnson DNA Repair Drugs Product and Services Table 194. Johnson & Johnson Recent Developments Table 195. Jonsson Comprehensive Cancer Center Corporation Information Table 196. Jonsson Comprehensive Cancer Center Description and Overview Table 197. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 198. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product and Services Table 199. Jonsson Comprehensive Cancer Center Recent Developments Table 200. Karyopharm Therapeutics Corporation Information Table 201. Karyopharm Therapeutics Description and Overview Table 202. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 203. Karyopharm Therapeutics DNA Repair Drugs Product and Services Table 204. Karyopharm Therapeutics Recent Developments Table 205. KuDOS Pharmaceuticals Corporation Information Table 206. KuDOS Pharmaceuticals Description and Overview Table 207. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 208. KuDOS Pharmaceuticals DNA Repair Drugs Product and Services Table 209. KuDOS Pharmaceuticals Recent Developments Table 210. National Health Service Corporation Information Table 211. National Health Service Description and Overview Table 212. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 213. National Health Service DNA Repair Drugs Product and Services Table 214. National Health Service Recent Developments Table 215. National Institutes of Health Corporation Information Table 216. National Institutes of Health Description and Overview Table 217. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 218. National Institutes of Health DNA Repair Drugs Product and Services Table 219. National Institutes of Health Recent Developments Table 220. Tesaro Corporation Information Table 221. Tesaro Description and Overview Table 222. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 223. Tesaro DNA Repair Drugs Product and Services Table 224. Tesaro Recent Developments Table 225. Key Raw Materials Lists Table 226. Raw Materials Key Suppliers Lists Table 227. DNA Repair Drugs Distributors List Table 228. DNA Repair Drugs Customers List Table 229. Research Programs/Design for This Report Table 230. Key Data Information from Secondary Sources Table 231. Key Data Information from Primary Sources List of Figures Figure 1. DNA Repair Drugs Product Picture Figure 2. Global DNA Repair Drugs Sales Market Share by Type in 2021 & 2028 Figure 3. PARP Inhibitors Product Picture Figure 4. Other Product Picture Figure 5. Global DNA Repair Drugs Sales Market Share by Application in 2021 & 2028 Figure 6. Oncological Use Case Figure 7. Stroke Use Case Figure 8. DNA Repair Drugs Report Years Considered Figure 9. Global DNA Repair Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global DNA Repair Drugs Market Size 2017-2028 (US$ Million) Figure 11. Global DNA Repair Drugs Sales (2017-2022) & (K Units) Figure 12. Global DNA Repair Drugs Market Size Market Share by Region: 2021 VS 2028 Figure 13. Global DNA Repair Drugs Sales Market Share by Region (2017-2022) Figure 14. Global DNA Repair Drugs Sales Market Share by Region in 2021 Figure 15. Global DNA Repair Drugs Revenue Market Share by Region in 2017 VS 2021 Figure 16. Global DNA Repair Drugs Sales Share by Manufacturers in 2021 Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by DNA Repair Drugs Sales in 2021 Figure 18. DNA Repair Drugs Revenue Share by Manufacturers in 2021 Figure 19. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 20. Global DNA Repair Drugs Revenue Share by Type (2017-2022) Figure 21. Global DNA Repair Drugs Revenue Growth Rate by Type in 2017 & 2021 Figure 22. Global DNA Repair Drugs Revenue Share by Application (2017-2022) Figure 23. Global DNA Repair Drugs Revenue Growth Rate by Application in 2017 & 2021 Figure 24. North America DNA Repair Drugs Sales Market Share by Type (2017-2028) Figure 25. North America DNA Repair Drugs Revenue Market Share by Type (2017-2028) Figure 26. North America DNA Repair Drugs Sales Market Share by Application (2017-2028) Figure 27. North America DNA Repair Drugs Revenue Market Share by Application (2017-2028) Figure 28. North America DNA Repair Drugs Sales Share by Country (2017-2028) Figure 29. North America DNA Repair Drugs Revenue Share by Country (2017-2028) Figure 30. U.S. DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 31. Canada DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 32. Europe DNA Repair Drugs Sales Market Share by Type (2017-2028) Figure 33. Europe DNA Repair Drugs Revenue Market Share by Type (2017-2028) Figure 34. Europe DNA Repair Drugs Sales Market Share by Application (2017-2028) Figure 35. Europe DNA Repair Drugs Revenue Market Share by Application (2017-2028) Figure 36. Europe DNA Repair Drugs Sales Share by Country (2017-2028) Figure 37. Europe DNA Repair Drugs Revenue Share by Country (2017-2028) Figure 38. Germany DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 39. France DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 40. U.K. DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 41. Italy DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 42. Russia DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 43. Asia Pacific DNA Repair Drugs Sales Market Share by Type (2017-2028) Figure 44. Asia Pacific DNA Repair Drugs Revenue Market Share by Type (2017-2028) Figure 45. Asia Pacific DNA Repair Drugs Sales Market Share by Application (2017-2028) Figure 46. Asia Pacific DNA Repair Drugs Revenue Market Share by Application (2017-2028) Figure 47. Asia Pacific DNA Repair Drugs Sales Share by Region (2017-2028) Figure 48. Asia Pacific DNA Repair Drugs Revenue Share by Region (2017-2028) Figure 49. China DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 50. Japan DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 51. South Korea DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 52. India DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 53. Australia DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 54. Taiwan DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 55. Indonesia DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 56. Thailand DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 57. Malaysia DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 58. Philippines DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 59. Vietnam DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 60. Latin America DNA Repair Drugs Sales Market Share by Type (2017-2028) Figure 61. Latin America DNA Repair Drugs Revenue Market Share by Type (2017-2028) Figure 62. Latin America DNA Repair Drugs Sales Market Share by Application (2017-2028) Figure 63. Latin America DNA Repair Drugs Revenue Market Share by Application (2017-2028) Figure 64. Latin America DNA Repair Drugs Sales Share by Country (2017-2028) Figure 65. Latin America DNA Repair Drugs Revenue Share by Country (2017-2028) Figure 66. Mexico DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 67. Brazil DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 68. Argentina DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 69. Middle East and Africa DNA Repair Drugs Sales Market Share by Type (2017-2028) Figure 70. Middle East and Africa DNA Repair Drugs Revenue Market Share by Type (2017-2028) Figure 71. Middle East and Africa DNA Repair Drugs Sales Market Share by Application (2017-2028) Figure 72. Middle East and Africa DNA Repair Drugs Revenue Market Share by Application (2017-2028) Figure 73. Middle East and Africa DNA Repair Drugs Sales Share by Country (2017-2028) Figure 74. Middle East and Africa DNA Repair Drugs Revenue Share by Country (2017-2028) Figure 75. Turkey DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 76. Saudi Arabia DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 77. U.A.E DNA Repair Drugs Revenue (2017-2028) & (US$ Million) Figure 78. DNA Repair Drugs Value Chain Figure 79. DNA Repair Drugs Production Process Figure 80. Channels of Distribution Figure 81. Distributors Profiles Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed

4SC AG ARCAGY/ GINECO GROUP Bristol Myers Squibb British Columbia Cancer Agency Cambridge University Hospitals NHS Foundation Trust Genentech Georgetown University German Breast Group GlaxoSmithKline Jiangsu Hengrui Medicine Johnson & Johnson Jonsson Comprehensive Cancer Center Karyopharm Therapeutics KuDOS Pharmaceuticals National Health Service National Institutes of Health Tesaro